Fiscal Year 2023 First Quarter Highlights
Net sales of $81.5 million increased 5.9% compared to the prior-year quarter
Med Tech net sales of $22.8 million increased 29.6%
Med Device net sales of $58.7 million decreased 1.1%
Gross margin of 51.9% declined 20 basis points year over year
GAAP loss per share of $0.33 and adjusted loss per share of $0.06
The Company commenced the Full Market Release of the AlphaVac F18 Mechanical Thrombectomy device
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.